Catastrophic antiphospholipid syndrome in a patient with systemic sclerosis and hereditary angioedema: case report and literature review

References

• Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346:752–763.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Crowther M, Branch W, et al. Antiphospholipid syndrome. Lancet. 2010;376:1498–1509.
   PubMed Web of Science ®Google Scholar
• Cervera R, Rodríguez-Pintó I. Catastrophic antiphospholipid syndrome: task force report summary. Lupus. 2014;23:1283–1285.
   PubMed Web of Science ®Google Scholar
• Pope JE. Scleroderma overlap syndromes. Curr Opin Rheumatol. 2002;14:704–710.
   PubMed Web of Science ®Google Scholar
• Balbir-Gurman A, Braun-Moscovici Y. Scleroderma overlap syndrome. Isr Med Assoc J. 2011;13:14.
   PubMed Web of Science ®Google Scholar
• Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359:1027–1036.
   PubMed Web of Science ®Google Scholar
• Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore). 2001;80:355–377.
   PubMed Web of Science ®Google Scholar
• Kane D, McSweeney F, Swan N, et al. Catastrophic antiphospholipid antibody syndrome in primary systemic sclerosis. J Rheumatol. 1998;25:810–812.
   Web of Science ®Google Scholar
• Flamholz R, Tran T, Grad GI, et al. Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapy. J Clin Apher. 1999;14:171–176.
   Web of Science ®Google Scholar
• Zoli A, D'Agostino MA, Pompa A, et al. Failure of aggressive anticoagulant therapy in catastrophic antiphospholipid syndrome. Clin Exp Rheumatol. 2000;18:113.
   Web of Science ®Google Scholar
• Cervera R. (2014). CAPS Registry [Internet]; [cited 2016 May 14]. Available from: http://www.med.ub.es/MIMMUN/FORUM/CAPS.HTM
   Google Scholar
• Ciołkiewicz M, Domysławska I, Kita K, et al. Secondary lethal catastrophic antiphospholipid syndrome in 24-years old female patient with overlap syndrome (systemic sclerosis and systemic lupus erythematosus). Pol Merkur Lekarski. 2006;20:337–340.
   Google Scholar
• Paola Triggianese MD, Guarino MD, Eleonora Ballanti MD, et al. Hereditary angioedema and autoimmunity. Isr Med Assoc J. 2014;16:622–624.
   Web of Science ®Google Scholar
• Spiera H, Oreskes I, Stimmel B. Rheumatoid factor activity in heroin addicts on methadone maintenance. Ann Rheum Dis. 1974;33:153–156.
   Web of Science ®Google Scholar
• Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–1027.
   PubMed Web of Science ®Google Scholar
• Parodi A, Drosera M, Barbieri L, et al. Antiphospholipid antibody system in systemic sclerosis. Rheumatology. 2002;40:111–112.
   Web of Science ®Google Scholar
• Pope JE, Thompson A. The frequency and significance of anticardiolipin antibodies in scleroderma. J Rheumatol. 2000;27:1450–1452.
   Web of Science ®Google Scholar
• Schoenroth L, Fritzler M, Lonzetti L, et al. Antibodies to beta2 glycoprotein I and cardiolipin in SSc. Ann Rheum Dis. 2002;61:183–184.
   Web of Science ®Google Scholar
• Malia RG, Greaves M, Rowlands LM, et al. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations. Clin Exp Immunol. 1988;73:456.
   PubMed Web of Science ®Google Scholar
• Cervera R, Khamashta MA, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2009;68:1428–1432.
   PubMed Web of Science ®Google Scholar
• Asherson RA, Cervera R, De Groot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530–534.
   PubMed Web of Science ®Google Scholar
• Bucciarelli S, Cervera R, Espinosa G, et al. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006;54:2568–2576.
   PubMed Web of Science ®Google Scholar
• Cervera R. Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome. Curr Rheumatol Rep. 2010;12:70–76.
   PubMedGoogle Scholar
• Nikolova M, Liubomirova M, Iliev A, et al. Clinical significance of antinuclear antibodies, anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies in heroin abusers. Isr Med Assoc J. 2002;4:908–910.
   Web of Science ®Google Scholar
• Kitchens CS, Erkan D, Brandão LR, et al. Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group. Am J Med. 2011;124:290–296.
   PubMed Web of Science ®Google Scholar
• Brickman CM, Tsokos GC, Below JE, et al. Immunoregulatory disorders associated with hereditary angioedema: I. Clinical manifestations of autoimmune disease. J Allergy Clin Immunol. 1986;77:749–757.
   PubMed Web of Science ®Google Scholar
• Ley SJ, Williams RC. A family with hereditary angioedema and multiple immunologic disorders. Am J Med. 1987;82:1046–1051.
   PubMed Web of Science ®Google Scholar
• Khan S, Tarzi MD, Doré PC, et al. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. Clin Immunol. 2007;123:14–17.
   Web of Science ®Google Scholar
• Pacheco TR, Weston WL, Giclas PC, et al. Three generations of patients with lupus erythematosus and hereditary angioedema. Am J Med. 2000;109:256–257.
   Web of Science ®Google Scholar
• Sérézal IG, Bouillet L, Dhôte R, et al. Hereditary angioedema and lupus: a French retrospective study and literature review. Autoimmun Rev. 2015;14:564–568.
   Web of Science ®Google Scholar
• Triggianese P, Chimenti MS, Toubi E, et al. The autoimmune side of hereditary angioedema: insights on the pathogenesis. Autoimmun Rev. 2015;14:665–669.
   PubMed Web of Science ®Google Scholar